FORT COLLINS, Colo — VetDC, Inc., a veterinary cancer therapeutics company, today announced the successful conclusion of a new field study of Tanovea®-CA1 (rabacfosadine), a novel small molecule therapy being developed as a treatment for lymphoma in dogs. This study … Keep Reading